Physiomics Plc

Equities

PYC

GB00BDR6W943

Professional Information Services

Market Closed - London S.E. Other stock markets 11:35:10 2024-05-21 am EDT			5-day change	1st Jan Change
1.25 ^GBX	0.00%		0.00%	-21.88%

May. 03	Physiomics warns large contracts taken longer than expected	AN
May. 03	AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal	AN

Physiomics plc Announces Board Changes, Effective April 1, 2022

March 29, 2022 at 02:00 am EDT

Physiomics plc announced that Dr. Tim Corn will join the Company's board as an Independent Non-Executive Director from 1 April 2022. Dr. Tim Corn qualified in medicine at King's College Hospital and, after becoming honorary Consultant and Senior Lecturer, joined the pharmaceutical industry in 1983.

Latest news about Physiomics Plc

Physiomics warns large contracts taken longer than expected	May. 03	AN
AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal	May. 03	AN
Physiomics Plc Increases Revenue Expectation for the Year 2025	May. 03	CI
Physiomics Plc Provides Earnings Guidance for the Financial Year Ending 30 June 2024	May. 03	CI
Transcript : Physiomics Plc, H1 2024 Earnings Call, Mar 18, 2024	Mar. 18
Physiomics celebrates "substantial" contract with old client	Mar. 18	AN
Physiomics Wins DNA-related Modeling Contract with Large Pharmaceutical Company	Mar. 18	MT
Physiomics plc Wins Contract by an Existing Pharma Client	Mar. 18	CI
Physiomics reports higher interim revenue; loss narrows	Mar. 07	AN
Physiomics Plc Reports Earnings Results for the Half Year Ended December 31, 2023	Mar. 07	CI
Physiomics celebrates contract award for cancer therapy insect model	Feb. 19	AN
The University of Sheffield Selects Physiomics plc to Support a Grant funded Project Focused on an Insect (Fruit Fly) Model of Cancer Treatment	Feb. 19	CI
Physiomics wins deal to support client's oncology assets	Feb. 05	AN
Physiomics plc Announces Contract Award	Feb. 05	CI
Transcript : Physiomics Plc - Special Call	Jan. 29
Physiomics appoints COO Sargent as new CEO; completes restructuring	Jan. 22	AN
Physiomics Names CEO as Nonexecutive Chairman	Jan. 22	MT
Physiomics Names CEO as Chairman	Jan. 22	MT
Physiomics plc Announces Chief Executive Officer Changes	Jan. 22	CI
Physiomics plc Announces Executive Changes	Jan. 22	CI
Transcript : Physiomics Plc - Special Call	Nov. 17
Physiomics Secures Grant to Advance Personalized Chemotherapy Tool in UK	Nov. 10	MT
Physiomics gets UK government grant for oncology dosing tool project	Nov. 10	AN
Physiomics plc Announces Change of Registered Office	23-10-04	CI
Physiomics Plc Appoints Dr Venkata Putcha, as Head of Biostatistics	23-10-03	CI

Chart Physiomics Plc

Duration

Period

More charts

Company Profile

Physiomics PLC is a United Kingdom-based company, which provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology. The Company offer its services by utilizing its proprietary Virtual Tumour predictive software, industry standard tools (such as NONMEM and MATLAB), as well as developing bespoke models using the R programming language. Virtual Tumour is a predictive quantitative systems' pharmacology (QSP) model used worldwide by global pharmaceuticals to small biotech companies to support oncology Research and development (R&D). It is a semi-mechanistic model that incorporates an abstracted representation of the cell cycle, Deoxyribonucleic acid (DNA) damage/ repair and elements of the immune response. The Company is also developing its technology for use in the field of personalized medicine. The Company is focused on helping pharma and biotech clients.

Sector

Professional Information Services

Calendar

2024-09-25 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Physiomics Plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Professional Information Services

	1st Jan change	Capi.
PHYSIOMICS PLC	-21.88%	2.15M
S&P GLOBAL, INC.	-0.15%	137B
THOMSON REUTERS CORPORATION	+21.93%	77.04B
MSCI, INC.	-10.63%	40.58B
WOLTERS KLUWER N.V.	+14.34%	38.07B
FACTSET RESEARCH SYSTEMS, INC.	-5.68%	17.25B
TRANSUNION	+11.51%	15.32B
COMPUTERSHARE LIMITED	+9.51%	10.44B
DUN & BRADSTREET HOLDINGS, INC.	-10.60%	4.71B
CLARIVATE PLC	-34.99%	3.96B

Other Professional Information Services